Capnea Injection (containing Caffeine Citrate) is a high-performance, CNS stimulant indicated for the treatment of apnea of prematurity (AOP) in newborn infants. By specifically stimulating the respiratory center in the brain and increasing the sensitivity of the lungs to carbon dioxide, Capnea effectively reduces the frequency and severity of breathing pauses (apnea). It is an essential, life-saving therapy in neonatal intensive care units (NICU), helping to stabilize the breathing patterns of premature infants and support their early respiratory development.
Using Capnea as part of a medically supervised neonatal care plan offers several targeted therapeutic benefits:
Effectively Reduces Apneic Episodes: Specifically targets the medullary respiratory center to trigger regular, rhythmic breathing in premature infants.
Enhances Pulmonary Function: Increases the volume of air breathed in (tidal volume) and improves the lungs' responsiveness to $CO_2$.
Accelerates Weaning from Ventilators: Clinically proven to help infants transition more successfully from mechanical ventilation or CPAP to independent breathing.
Provides CNS Stimulation: Stimulates the central nervous system to maintain an alert state of respiratory effort.
Reduces the Risk of Bronchopulmonary Dysplasia: By minimizing the need for prolonged mechanical ventilation, it helps protect the delicate lung tissue of the newborn.
Capnea Injection (Caffeine Citrate) is manufactured by Incepta Pharmaceuticals Ltd., a globally recognized pharmaceutical leader based in Bangladesh. Produced in state-of-the-art, WHO-GMP certified facilities that adhere to the strictest international safety and sterile manufacturing standards, Incepta ensures that every ampoule of Capnea meets rigorous criteria for purity, pH stability, and clinical potency. At Sanlive Pharmacy, we source Capnea directly from verified Incepta distributors to ensure neonatal units in Nigeria receive authentic, high-standard medication for their smallest patients.
Capnea utilizes a targeted stimulant mechanism for respiratory stabilization:
Caffeine Citrate (20mg/ml): A methylxanthine that acts as a competitive antagonist at adenosine receptors, leading to increased respiratory drive and diaphragm strength.
Sterile Aqueous Vehicle: Formulated for intravenous infusion or oral administration with precise osmotic compatibility for neonates.
To achieve optimal results with Capnea Injection, follow these guidelines:
Suggested Dosage: The dose is strictly calculated by a neonatologist based on the infant's birth weight, typically starting with a loading dose of 20mg/kg, followed by a daily maintenance dose of 5mg/kg.
Administration: Usually administered via a slow intravenous (IV) infusion over 30 minutes using a precision syringe pump.
Timing: The maintenance dose is generally started 24 hours after the initial loading dose and continued until the infant's respiratory pattern is stable (usually until 32–34 weeks post-menstrual age).
Monitoring: Regular monitoring of the infant's heart rate (to prevent tachycardia) and blood caffeine levels is essential during treatment.
Important Safety Note: Capnea must only be administered in a hospital setting under the direct supervision of a neonatologist or pediatrician. Common side effects may include irritability, tremors, or an increased heart rate. If the infant experiences seizures or severe vomiting, medical protocols for caffeine toxicity must be followed immediately. Use with caution in infants with existing heart or kidney conditions.
As a trusted provider of healthcare products in Nigeria, Sanlive Pharmacy ensures you receive only the best:
100% Genuine Products: Sourced from Incepta-verified distributors with guaranteed potency and origin.
Fast Nationwide Delivery: We ship to Lagos, Abuja, Port Harcourt, Kano, and across Nigeria.
International Shipping: We also ship abroad to London, USA, UAE, Saudi Arabia, and Europe, ensuring our products reach you wherever you are.
Professional Support: Get expert advice and quick ordering via our WhatsApp support line.
Yes. In many clinical settings, the same sterile injection solution can be administered enterally (orally or via a gastric tube) once the infant's digestive system is stable, as it is highly bioavailable.
Treatment is typically continued until the infant has been free of significant apneic episodes for 5 to 7 days, or until they reach a level of neurological maturity where they can breathe consistently on their own.
You can purchase authentic Incepta Capnea online through Sanlive Pharmacy & Stores for secure payment and fast, reliable delivery to hospitals and clinics.
No reviews yet.
Login to write a review.
Related Products
